RecruitingNCT07189494

European Newborn Study: Early Markers for a Better LifE

ENSEMBLE: European Newborn Study: Early Markers for a Better LifE


Sponsor

dr. M.J.N.L. Benders

Enrollment

1,000 participants

Start Date

Oct 6, 2023

Study Type

OBSERVATIONAL

Conditions

Summary

The goal of this observational study is to create a computer model to help doctors predict any problems occurring during development of babies after being diagnosed with brain injury. This will help provide better care to future babies. Next to this, the experiences of parents or caregivers surrounding the first two years after birth of a baby at risk of developing cerebral palsy will be researched to develop recommendations to support parents. Parents of participants will: \- Fill in two online questionnaires, one when their child is 3-4 months corrected age. The second when their child is 2 years corrected age. For the child no additional tests are needed. Only tests that are part of standard clinical practice are performed and are also saved in the study database.


Eligibility

Min Age: 0 YearsMax Age: 2 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a new treatment for people with cerebral palsy. The study is currently recruiting participants at 8 locations.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(8)

Assistance Publique Hôpitaux de Paris

Paris, France

University Hospital Essen

Essen, Germany

Ospedale Pediatrico Meyer Firenze

Florence, Italy

Istituto Giannina Gaslini

Genova, Italy

Ospedale Maggiore di Milano

Milan, Italy

Fondazione Stella Maris

Pisa, Italy

UMC Utrecht

Utrecht, Netherlands

University Hospital La Paz

Madrid, Spain

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07189494


Related Trials